Our Values. Quality Intelligent efforts in everyday practice. Innovation Change that unlocks new value. Performance Passion for results

Size: px
Start display at page:

Download "Our Values. Quality Intelligent efforts in everyday practice. Innovation Change that unlocks new value. Performance Passion for results"

Transcription

1 Product Guide

2 Our Values 1 Innovation Change that unlocks new value Our continuous progress and growth depends on the investments we make on scientific research for new medicines and technologies. Innovation is part of our DNA and a process involving multiple aspects of dynamic activities 2 Quality Intelligent efforts in everyday practice We pay attention to detail and take decisions over the acknowledgement that our reputation depends on the empowerment of every individual to respond efficiently, perform proactively and act with care in the service of our customers 3 Performance Passion for results 4 Integrity Transparency in all we do Our employees are the driving force of our success. We embrace them with pride and trust and empower them to achieve operational excellence through knowledge sharing and continuous improvement Transparency and honesty are embedded in our DNA. Our company s code of conduct ensures that all our employees and partners make decisions that are consistent with our values, achieving the highest quality standards in our operating model 5 Leadership We walk our talk We promote a positive working environment, applying visionary leadership style to influence and achieve excellent results. Our leaders step outside the executive suit and do things that symbolize our shared vision

3 Table of Contents Ophthalmic 5 Preservative free Long Acting 9 Injectables Generic Finished 13 dosage Active 29 Pharmaceutical Ingredients Pharmathen Product list 3

4

5 Ophthalmic Preservative free in multi-dose vials «Approaching the market with the sophisticated, cost effective and convenient multidose preservative free products» Pharmathen Product list 5

6 Ophthalmic Preservative free in multi-dose vials PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS BIMATOPROST PRESERVATIVE FREE Eye drops solution multi dose container 0.3mg/ml Reduction of elevated intraocular pressure in chronic openangle glaucoma and ocular hypertension in adults New BIMATOPROST TIMOLOL PRESERVATIVE FREE Eye drops solution multi dose container 0.3mg/ml & 5mg/ml Reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues. New CHLORAMPHENICOL PRESERVATIVE FREE Eye drops solution multi dose container 5mg/ml Topical antibacterial in the treatment of superficial ocular infections New CROMOGLYCATE SODIUM PRESERVATIVE FREE Eye drops solution multi dose container 20mg/ml For the relief and treatment of the eye symptoms of hayfever Q DEXAMETHASONE PRESERVATIVE FREE Eye drops solution multi dose container 1mg/ml Treatment of non-infectious inflammatory conditions Q DORZOLAMIDE/ TIMOLOL PRESERVATIVE FREE Eye drops solution multi dose container 20mg/ml & 5mg/ml Intraocular pressure elevation treatment

7 Ophthalmic Preservative free in multi-dose vials PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS DORZOLAMIDE PRESERVATIVE FREE Eye drops solution multi dose container 20mg/ml Intraocular pressure elevation treatment HYPROMELLOSE Eye drops solution multi dose container 3.2mg/ml Used as artificial tears to prevent damage to the cornea. Also moistens hard contact lenses and lubricates artificial eyes. Q LATANOPROST PRESERVATIVE FREE Eye drops solution multi dose container 0.05mg/ml Reduction of elevated intraocular pressure Q LATANOPROST TIMOLOL PRESERVATIVE FREE Eye drops solution multi dose container 0.05mg/ml & 5mg/ml Reduction of intraocular pressure (IOP) in patients with open angle glaucoma and ocular hypertension Q TIMOLOL PRESERVATIVE FREE Eye drops solution multi dose container 2.5mg/ml 5mg/ml Elevated intraocular pressure decrease TRAVOPROST PRESERVATIVE FREE Eye drops solution multi dose container 40mcg/ml Elevated intraocular pressure decrease TRAVOPROST PRESERVATIVE FREE Eye drops solution multi dose container 30mcg/ml Elevated intraocular pressure decrease Q TRAVOPROST & TIMOLOL PRESERVATIVE FREE Eye drops solution multi dose container 40mcg/ml & 5mg/ml Elevated intraocular pressure decrease New Pharmathen Product list 7

8

9 Long Acting Injectables «We are changing the perception of conventional injectable medication, improving the effectiveness of drug therapy and enhancing patient compliance» Pharmathen Product list 9

10 LAI s PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS RISPERIDONE long-acting Injectable 12.5mg/vial 25mg/vial 37.5mg/vial 50mg/vial Acute and chronic schizophrenic psychoses treatment Q ARIPIPRAZOLE long-acting Injectable 300mg/vial 400mg/vial Treatment of schizophrenia Under development EXENATIDE long-acting Injectable 2mg/vial Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus Q LANREOTIDE long-acting Injectable 60mg/vial 90mg/vial 120mg/ vial Treatment of acromegaly Q LEUPROLIDE ACETATE long-acting Injectable 3.75mg/vial 7.5mg/vial 11.5mg/vial 22.5mg/vial 30mg/vial 45mg/vial Palliative treatment of advanced prostatic cancer and management of endometriosis Q4 2017

11 LAI s PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS OCTREOTIDE ACETATE long-acting Injectable 10mg/vial 20mg/vial 30mg/vial Treatment of acromegaly and control symptoms such as diarrhea or flushing in patients with tumors Q PALIPERIDONE PALMITATE long-acting Injectable 25mg/vial 50mg/vial 75mg/vial 100mg/ vial 150mg/vial Indicated for the treatment of schizophrenia in adult patients Q Pharmathen Product list 11

12

13 Generic finished dosage «Research, Innovation and IP protection at the disposal of our highly competitive business model» Pharmathen Product list 13

14 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS ALENDRONATE & CHOLECALCIFEROL tablets 70mg/2800IU 70mg/5600IU Postmenopausal osteoporosis APREPITANT hard capsules 80mg, 125mg, 165mg Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy in adults Q ARIPIPRAZOLE orodispersible tablets 10mg, 15mg, 30mg Schizophrenia, manic episode treatment ARIPIPRAZOLE tablets 5mg, 10mg 15mg, 30mg Schizophrenia, manic episode treatment ATOMOXETINE hard capsules 10mg, 18mg 25mg, 40mg 60mg, 80mg & 100mg Treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD) New ATORVASTATIN f.c. tablets 10mg, 20mg 40mg, 80mg Hypercholesterolaemia treatment, cardiovascular disease prevention BIMATOPROST eye drops, solution 0.1mg/ml 0.3mg/ml Reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension

15 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS BRINZOLAMIDE eye drop suspension 10mg/ml Intraocular Pressure Elevation Treatment & Open-angle Glaucoma CASPOFUNGIN powder for concentrate for solution for infusion 50 mg, 70mg Invasive candidiasis, invasive aspergillosis treatment New CEFUROXIME AXETIL f.c. tablets 125mg, 250mg 500mg Mild to severe infections treatment CIPROFLOXACIN solution for infusion 100mg/50ml 200mg/100ml 400mg/200ml Infections treatment CIPROFLOXACIN f.c. tablets 250mg, 500mg 750mg Infections treatment CISATRACURIUM BESYLATE solution for injection / infusion 2mg/ml, 5mg/ml Adjunct to general anaesthesia CLOPIDOGREL f.c. tablets 75mg Prevention of Atherothrombotic & Thomboembolic Events DARUNAVIR f.c tablets 75mg, 150mg, 300mg, 400mg, 600mg & 800mg Treatment of patients with human immunodeficiency virus (HIV-1) infection Q Pharmathen Product list 15

16 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS DIMENHYDRINATE Sublingual tablets 50mg Prevention and treatment of motion sickness. Symptomatic treatment of short duration of nausea and vomiting not accompanied with fever. DIMETHYL FUMARATE Gastro resistant hard capsules 120mg, 240mg Treatment of adult patients with relapsing remitting multiple sclerosis Q DORZOLAMIDE Eye drops solution 20mg/ml Intraocular pressure elevation treatment DORZOLAMIDE / TIMOLOL Eye drops solution 20mg/ml & 5mg/ml Intraocular pressure elevation treatment DULOXETINE hard gastro-resistant capsules 30mg, 60mg Treatment of depression and generalized anxiety disorder. Treatment of diabetic peripheral neuropathic pain ENOXAPARIN solution for injection 20mg/0.2ml 40mg/0.4ml 60mg/0.6ml 80mg/0.8ml 100mg/1ml Antithrombotic ENTECAVIR f.c tablets 0.5mg, 1mg Indicated for the treatment of chronic hepatitis B virus (HBV) infection Q2 2016

17 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS EPLERENONE f.c. tablets 25mg, 50mg Beta-blockers therapy ESCITALOPRAM f.c. tablets 5mg, 10mg 15mg, 20mg Major depressive episodes, Panic disorder, social anxiety disorder, generalized anxiety disorder & obsessive-compulsive disorder treatment ESOMEPRAZOLE powder for solution for injection/infusion 40mg Gastric antisecretory treatment for adults and children FEBUXOSTAT f.c tablets 80mg, 120mg Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred Q FINASTERIDE f.c. tablets 5mg Benign prostatic hyperplasia (BPH) treatment and control FINGOLIMOD hard capsules 0.5mg Indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis Q FLUCONAZOLE solution for infusion 50mg/25ml 100mg/50ml 200mg/100ml 400mg/200ml Anti-infective therapy Pharmathen Product list 17

18 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS FLUVASTATIN XL prolonged release tablets 80mg Dyslipidaemia adjunct to diet & Secondary prevention in coronary heart disease GALANTAMINE f.c. tablets 4mg, 8mg, 12mg Dementia of the Alzheimer type symptomatic treatment GALANTAMINE SR prolonged-release hard capsules 8mg, 16mg 24mg Dementia of the Alzheimer type symptomatic treatment IBANDRONATE concentrate for solution for infusion 1mg/1ml 2mg/2ml 6mg/6ml Prevention of Skeletal Events & Treatment of Hypercalcaemia IBANDRONATE f.c. tablets ONCE A MONTH 150mg Postmenopausal osteoporosis treatment IBANDRONATE f.c. tablets 50mg Prevention of Skeletal Events in Patients with Cancer IRBESARTAN f.c. tablets 75mg, 150mg 300mg Essential hypertension treatment IVABRADINE f.c tablets 5mg, 7.5mg Treatment of coronary artery disease New

19 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS ISOTRETINOIN soft gel. capsules 5mg, 10mg 20mg Severe forms of acne treatment LEFLUNOMIDE f.c. tablets 10mg, 20mg 100mg Active rheumatoid arthritis treatment psoriatic arthritis treatment LEVETIRACETAM concetrate for solution for infusion 100mg/ml Epilepsy treatment LEVETIRACETAM oral solution 100mg/ml Epilepsy treatment LEVETIRACETAM f.c. tablets 250mg, 500mg 750mg, 1000mg Epilepsy treatment LEVOFLOXACIN solution for infusion 5mg/ml Infections treatment LEVOFLOXACIN f.c. tablets 250mg, 500mg Infections treatment LINEZOLID f.c. tablets 600mg LINEZOLID solution for infusion 600mg/300ml Nosocomial & community acquired pneumonia treatment Nosocomial & community acquired pneumonia treatment Pharmathen Product list 19

20 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS LOSARTAN f.c. tablets 12.5mg, 25mg 50mg, 100mg Essential hypertension treatment LOSARTAN +HCTZ f.c. tablets 50/12.5mg 100/25mg Essential hypertension treatment MEMANTINE f.c.tablets 10mg, 20mg Moderate to Severe Alzheimer s Disease Treatment MEROPENEM powder for solution for injection or infusion 500mg, 1g Infections treatment MONTELUKAST f.c.tablets 10mg Asthma treatment MONTELUKAST chewable tablets 4mg, 5mg Asthma treatment MOXIFLOXACIN Eye drops solution 5 mg/ml Bacterial infections treatment MOXIFLOXACIN f.c. tablets 400mg Bacterial infections treatment

21 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS MOXIFLOXACIN solution for infusion 400mg/250ml Bacterial infections treatment OLANZAPINE orodispersible tablets 5mg, 10mg 15mg, 20mg Treatment of Schizophrenia or Manic Episode bipolar disorder recurrence prevention (manic episode patients responding to therapy) OLANZAPINE f.c. tablets 2.5mg, 5mg 7.5mg, 10mg 15mg, 20mg Treatment of Schizophrenia or Manic Episode bipolar disorder recurrence prevention (manic episode patients responding to therapy) OLANZAPINE powder for solution for injection 10mg/vial Treatment of Schizophrenia or Manic Episode bipolar disorder recurrence prevention (manic episode patients responding to therapy) ONDANSETRON solution for Injection 4mg/2ml 8mg/4ml Management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of post-operative nausea and vomiting. Pharmathen Product list 21

22 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS ONDANSETRON f.c. tablets 4mg, 8mg Management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of post-operative nausea and vomiting. PALIPERIDONE prolonged-release tablets 1.5mg, 3mg, 6mg, 9mg, 12mg Schizophrenia treatment Q PARICALCITOL solution for injection 5mcg/ml, 10mcg/2ml, 2mcg/ml, 4mcg/2ml Prevention and treatment of secondary hyperparathyroidism in patients with chronic renal failure undergoing aemodialysis. PRAMIPEXOLE tablets 0.088mg, 0.18mg, 0.35mg, 0.7mg, 1.1mg Parkinson's disease treatment. Treatment of moderate to severe idiopathic Restless Legs Syndrome PRASUGREL f.c tablets 5mg, 10mg Prevention of atherothrombotic events in adult patients with acute coronary syndrome Q1 2017

23 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS PREGABALIN capsules, hard 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg Neuropathic pain, epilepsy and generalised anxiety disorder treatment QUETIAPINE SR prolonged-release tablets 50mg, 150mg, 200mg, 300mg, 400mg Schizophrenia and bipolar disorder treatment RALOXIFENE f.c. tablets 60mg Postmenopausal osteoporosis treatment and prevention REPAGLINIDE tablets 0.5mg, 1mg, 2mg Type 2 diabetes adjunct to diet RISEDRONATE f.c. tablets 5mg, 30mg, 35mg Postmenopausal Osteoporosis Treatment & Paget's disease (30mg). Treatment of osteoporosis in men at high risk of fractures (35mg) RISPERIDONE f.c. tablets 0.5mg, 1mg, 2mg, 3mg, 4mg, 6mg Acute and chronic schizophrenic psychoses treatment Pharmathen Product list 23

24 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS RIVASTIGMINE oral solution 2mg/ml Dementia of the Alzheimer type symptomatic treatment. Treatment of dementia in patients with idiopathic Parkinson's disease. RIVASTIGMINE hard capsules 1.5mg, 3mg, 4.5mg, 6mg Dementia of the Alzheimer type symptomatic treatment. Treatment of dementia in patients with idiopathic Parkinson's disease. RIZATRIPTAN orodispersible tablets 5mg, 10mg RIZATRIPTAN tablets 5mg, 10mg Headache phase of migraine attacks acute treatment Headache phase of migraine attacks acute treatment ROPINIROLE f.c. tablets 0.25mg, 0.5mg 1mg, 2mg, 5mg Parkinson's disease treatment ROPINIROLE SR prolonged-release tablets 2mg, 3mg, 4mg 8mg Parkinson's disease treatment ROPIVACAINE solution for infusion in bags 100ml, 200ml 2 mg/ml Surgical anaesthesia & acute pain management

25 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS ROPIVACAINE solution for injection In vials 10ml, 20ml 2 mg/ml, 5.0 mg/ml, 7.5 mg/ml, 10 mg/ml Surgical anaesthesia & acute pain management SEVELAMER CARBONATE f.c. tablets 800mg Hyperphosphataemia control SEVELAMER HCL f.c. tablets 800mg Hyperphosphataemia control SILDENAFIL f.c. tablets 25mg, 50mg, 100mg Erectile dysfunction in adult males treatment TEICOPLANIN powder & solvent for solution for injection 100mg, 200mg, 400mg Infections treatment TOLTERODINE f.c. tablets 1mg, 2mg Urge incontinence Symptomatic treatment TOLTERODINE SR prolonged-release hard capsules 2mg, 4mg Urge incontinence Symptomatic treatment TOPIRAMATE f.c. tablets 25mg, 50mg, 100mg, 200mg Epilepsy treatment Pharmathen Product list 25

26 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS TRANDOLAPRIL capsules 0.5mg, 1mg 2mg, 4mg Mild or moderate hypertension TRAVOPROST eye drops solution 40mcg/ml TRAVOPROST eye drops solution 30mcg/ml Elevated intraocular pressure decrease Elevated intraocular pressure decrease Q TRAVOPROST & TIMOLOL eye drops solution 40 mcg/ml & 5 mg/ml Elevated intraocular pressure decrease New TRIFUSAL powder for oral suspension 600mg Secondary prophylaxis after a first coronary or cerebrovascular ischaemic event New VALACICLOVIR f.c. tablets 500mg Herpes zoster, herpes simplex therapy & CMV infection prophylaxis VALGANCICLOVIR f.c. tablets 450mg Cytomegalovirus (CMV) retinitis in patients with AIDS treatment New VENLAFAXINE IR tablets 37.5mg, 50mg 75mg Treatment & recurrence prevention for major depressive episodes generalized anxiety disorder, social anxiety disorder & panic disorder treatment

27 Generic finished dosage PRODUCT PHARMACEUTICAL FORM STRENGTHS THERAPEUTIC CATEGORY DOSSIER STATUS VENLAFAXINE Prolonged release hard capsules 37.5mg, 75mg 150mg Treatment & recurrence prevention for major depressive episodes generalized anxiety disorder, social anxiety disorder & panic disorder treatment VORICONAZOLE f.c. tablets 50mg, 200mg Broad spectrum antifungal VORICONAZOLE powder for solution for infusion 200mg Broad spectrum antifungal Pharmathen Product list 27

28

29 Active Pharmaceutical Ingredients «We transform new knowledge to innovative synthetic processes, designed to ensure quality, efficiency and sustainability» Pharmathen Product list 29

30 APIs Commercially PRODUCT INDICATION DMF STATUS Aprepitant Prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) and for prevention of postoperative nausea and vomiting Q Aripiprazole Treatment of Schizophrenia Brinzolamide Ocular hypertension / Open angle Glucoma Duloxetine HCl Depressive disorder Febuxostat Chronic management of Hyperuricemia Q Fluvastatin Na Cholesterol Lowering Ibandronate Na H2O Treatment & Prevention of Postmenopausal Osteoporosis Ivabradine HCl Angina Q Linezolid Infection treatment Paliperidone Treatment of Schizophrenia Q Pregabalin Management of neuropathic pain and treatment of epilepsy

31 APIs Commercially PRODUCT INDICATION DMF STATUS Polyquaternium-1 Ophthalmic solution preservative Technical package Ropinirole HCl Parkinson s Ropivacaine Anesthesia Tolterodine Tartrate Treatment of Over active bladder Valganciclovir HCl Treatment of Cytomegalovirus (CMV) Retinitis Venlafaxine HCl Depressive disorder Voriconazole Treatment of Inasive Aspergillosis fungal infection Pharmathen Product list 31

32 APIs R&D PRODUCT INDICATION SAMPLES STABILITY DATA FROM LAB TECHNICAL PACK Agomelatine Antidepressant Clopidogrel Acute Coronary Syndrome Dimethyl fumarate Immunomodulator Entecavir Hepatitis B infection Ezetimibe Cholesterol Lowering Fingolimod HCl Treatment of multiple sclerosis Mirabegron Treatment of overactive bladder ODV succinate Antidepressant, non-hormonal treatment for menopause Paliperidone palmitate Treatment of Schizophrenia

33 APIs R&D PRODUCT INDICATION SAMPLES STABILITY DATA FROM LAB TECHNICAL PACK Rivaroxaban Reduce the risk of stroke and systemic embolism. Treatment of Deep Vein Thrombosis. Treatment of Pulmonary Embolism Rizatriptan benzoate Headache phase of Migraine Attacks Acute Treatment Rosuvastatin Ca Cholesterol Lowering Solifenacin succinate Treatment of overactive bladder Strontium ranelate Tadalafil Treatment & Prevention of Postmenopausal Osteoporosis Erectile Dysfunction & Benign Prostatic Hyperplasia Pharmathen Product list 33

34 APIs Pipeline PRODUCTS UNDER EVALUATION INDICATION Ambrisentan Dabigatran Deferasirox Dronedarone Fesoterodine Lacosamide Perampanel Raltegravir Rilpivirine Roflumilast Sitagliptin Ticagrelor Topiroxostat Antihypertensive Antithrombotic Chelating agent Antiarrhythmic Antimuscarinic Anticonvulsant, Analgesic Antiepileptic Antiviral Antiviral Antiasthmatic Antidiabetic Platelet aggregation inhibitor Anti-gout Vildagliptin Antidiabetic

35 Pharmathen Product list 35

36 Pharmathen S.A., Headquarters 44, Kifissias Avenue Marousi Athens-Greece T: F: Pharmathen UK Ground Floor South Wing 10 Bricket Road St Albans AL1 3JX United Kingdom T: +44 (0)

We embrace science and innovation

We embrace science and innovation Product Catalogue We embrace science and innovation TABLE of CONTENTS 8 Long Acting Injectables 12 Differentiated Products Preservative Free Ophthalmics in Multi-Dose Vials 16 Differentiated Products Oral

More information

Innovative Products Available. OTC Products Available

Innovative Products Available. OTC Products Available Innovative Products Benfotiamine film-coated tablets 150 mg Cholecalciferol film-coated tablets 22400 I.U. Diltiazem rectal ointment 2% Agents for Treatment of Hemorrhoids and Fissures Blood and Blood

More information

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole

More information

LIST OF DRUGS DURING 2004

LIST OF DRUGS DURING 2004 LIST OF DRUGS DURING 2004 S.NO Name Of Drug Pharmacological Classification Date of Approval 188 Dutasteride For BPH 16-02-2004 189 Gefitinib Anti-cancer 17-02-2004 190 Imidapril Anti-hypertensive 23-02-2004

More information

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M. April 2018 The usual quarterly of Category M prices Another set of similar comments as I made in January: significant increases in many lines which have been subject to price concessions but even more

More information

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY tlo_seledyn.pdf 1 22.08.2017 14:38:01 C M Y CM MY CY CMY K DOSSIER LIST tlo_seledyn.pdf 1 22.08.2017 14:38:01 PRODUCT NAME PHARMACEUTICAL FORM STRENGTH REFERENCE THERAPEUTIC CLASS ALIMENTARY TRACT & METABOLISM

More information

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M % June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has

More information

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6 Abiraterone Tablet 250 mg Q4 2016 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Available Alendronic Acid Tablet 70 mg Available Amikacin Solution for injection 50 mg/ml; 125mg/ml;

More information

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5 Abiraterone Tablet 250 mg Q4 2015 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Q4 2014 Alendronic Acid Tablet 70 mg Available Amisulpride Tablet 50 ; 100 ; 200 ; 400 mg Available

More information

Orodispersible tablets & Tablets

Orodispersible tablets & Tablets LIFE PHARMA PRODUCTS Generics SPAIN PRODUCT STRENGTHS PHARM.FORM INDICATION Acarbose 50mg-100mg Antidiabetic Acyclovir 5% Labial stick Antiviral Alendronate 70mg Musculo-skeletal system Amikacin 500mg/2ml

More information

Orchid Chemicals & Pharmaceuticals Ltd. Orchid Towers 313, Valluvar Kottam High Road, Nungambakkam, Chennai , India. Tel : (91)

Orchid Chemicals & Pharmaceuticals Ltd. Orchid Towers 313, Valluvar Kottam High Road, Nungambakkam, Chennai , India. Tel : (91) R Orchid Chemicals & Pharmaceuticals Ltd. Orchid Towers 313, Valluvar Kottam High Road, Nungambakkam, Chennai 600 034, India. Tel : (91) 4428211000 Fax : (91) 4428211002 Email : corporate@orchidpharma.com

More information

Pharmacotherapy Handbook

Pharmacotherapy Handbook Pharmacotherapy Handbook Eighth Edition Barbara G. Wells, PharmD, HP, FCCP, BCPP Dean and Professor Executive Director, Research Institute of Pharmaceutical Sciences School of Pharmacy, The University

More information

CONTACT POLPHARMA GROUP POLPHARMA B2B

CONTACT POLPHARMA GROUP POLPHARMA B2B DOSSIER FDFLIST Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM 1. Esomeprazole sodium or injection 40 mg Nexium / AstraZeneca Antiulcerant 2. Omeprazole

More information

Pharmacy Prep. Qualifying Pharmacy Review

Pharmacy Prep. Qualifying Pharmacy Review Pharmacy Prep 2014 Misbah Biabani, Ph.D Director, Tips Review Centres 5460 Yonge St. Suites 209 & 210 Toronto ON M2N 6K7, Canada Luay Petros, R.Ph Pharmacy Manager, Wal-Mart, Canada 1 Disclaimer Your use

More information

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M % December 16 No Category M changes so the reductions imposed in May which were only supposed to last until September continue As in November, most changes are Category A lines with a few Category C. Significant

More information

DT Description Price Category Price change

DT Description Price Category Price change Tariff T Watch October 2014 Readers are no doubt aware of this quarter's bad news for primary care prescribing allocations: NHS England has d the remuneration mechanism for community pharmacies gaining

More information

DT Description Price Category Price change Percentage

DT Description Price Category Price change Percentage June 2017 A slight inflationary pressure in most CCGs from mainly Category A increases. Significant price increases: Most of low concern although those involving the less frequently used tamoxifen strengths

More information

STEP THERAPY PROGRAM

STEP THERAPY PROGRAM STEP THERAPY PROGRAM Step Therapy Program Certain prescription drugs call for a more detailed assessment to help ensure that they represent reasonable treatment. For these drugs, Great-West s Special Authorization

More information

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 723 February 2018 Pan-Canadian Select Molecule Price Initiative for Generic Drugs Alberta Drug Benefit List prices

More information

Area Drug and Therapeutics Committee Prescribing Supplement No 6 December 2004

Area Drug and Therapeutics Committee Prescribing Supplement No 6 December 2004 Area Drug and Therapeutics Committee Prescribing Supplement No 6 In this issue Drugs currently being considered by the SMC Advice due on 13. Joint Formulary Update. Drugs currently being considered by

More information

Kern Pharma Portfolio 2014

Kern Pharma Portfolio 2014 Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN

More information

Nclex para la Enfermera Hispana

Nclex para la Enfermera Hispana Nclex para la Enfermera Hispana Drug Classifications The following is a list of the major drug classifications, Memory tricks" are included where applicable (Retrieved from https://ncsbn.com) A Antianemics:

More information

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi Joseph T. DiPiro, PharmD, FCCP Panoz Professor of Pharmacy, College

More information

Alimentary Tract and Metabolism

Alimentary Tract and Metabolism Alimentary Tract and Metabolism Antiemetic Aprepitant 80 & 125 mg Tablets Greece Q3 2016 2017 Type 3 Antacid Almagate 1,5 g Liquid stick pack Spain Q1 2017 Q1 2018 Type 1 Antacid Almagate 500mg Tablets

More information

Manufacturing and Marketing permission issued from SND Division from to

Manufacturing and Marketing permission issued from SND Division from to Manufacturing and Marketing permission issued from SND Division from 01.01.2018 to 31.05.2018. S.No Drug Name Composition Indication Date of Approval As a component of multi agent Pegaspargase Each vial

More information

CHRONIC TREATMENT GUIDELINES

CHRONIC TREATMENT GUIDELINES CHRONIC TREATMENT GUIDELINES REGISTRATION OF CHRONIC CONDITIONS You can only access benefits for chronic medication, as listed below, if your prescribing/treating doctor or pharmacist registers your chronic

More information

How much do you know about illnesses or health problems for your parents, grandparents, brothers, sisters, and/or children? 1 A lot Some None at all

How much do you know about illnesses or health problems for your parents, grandparents, brothers, sisters, and/or children? 1 A lot Some None at all Family Health History Please answer each question as honestly as possible. There are no right or wrong answers to nay of the questions. It is important that you answer as many questions as you can. We

More information

CHRONIC MEDICINE PROGRAMME GENERAL INFORMATION LETTER

CHRONIC MEDICINE PROGRAMME GENERAL INFORMATION LETTER RAND WATER MEDICAL SCHEME RAND WATER MEDICAL SCHEME CHRONIC MEDICINE PROGRAMME GENERAL INFORMATION LETTER LIST OF CHRONIC CONDITIONS Conditions covered under s chronic medication benefit are detailed below.

More information

SCHEDULE OF CONTINUING EDUCATION COURSES FOR RN s and CNAs. January 2018

SCHEDULE OF CONTINUING EDUCATION COURSES FOR RN s and CNAs. January 2018 January 201 DATE DAY TIME TOPICS TOTAL January 04 1. Understanding Fibromyalagia 2. Diabetes and Cardiovascular Disease 3. Prostate Cancer 4. Hepatitis C 5. Understanding Hepatitis B January 11 1. Dysphagia

More information

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH 1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder

More information

Medicines Formulary BNF Section 4 Central Nervous System

Medicines Formulary BNF Section 4 Central Nervous System Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam

More information

QTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8

QTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 2019 LiveWELL Health Plan PREVENTIVE DRUG LIST - GENERIC Names ( Copay) - ALPHABETICAL by DRUG CATEGORY You should always check with your prescriber and/or pharmacist to determine if these alternatives

More information

Chapter 4 ~ Central nervous system

Chapter 4 ~ Central nervous system Chapter 4 ~ Central Nervous System: Special Section 1 of 5 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics LOPRAZOLAM Tablet 1mg LORMETAZEPAM Tablet 500microgram PROMETHAZINE

More information

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5

More information

EVIDENCE-BASED VITAMIN AND MINERAL USAGE SUMMARY TABLE (APRIL 2002)

EVIDENCE-BASED VITAMIN AND MINERAL USAGE SUMMARY TABLE (APRIL 2002) Acne Acrodermatitis Enteropathica Adrenal Support Age Related Cognitive Decline Alcoholism/Alcohol Withdrawal Alzheimer's Disease Amenorrhoea Anaemia Angina Anorexia Nervosa Anxiety Asthma Atherosclerosis

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Guidelines for the medical treatment of chronic open angle glaucoma and ocular hypertension Summary: DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Diagnosis and management of ocular hypertension (OHT)

More information

SCHEDULE OF CONTINUING EDUCATION COURSES FOR RN s and CNAs. January 2018 WALK INS ARE ACCEPTED BUT WE ADVISE STUDENTS TO PRE-REGISTER BEFORE THURSDAY

SCHEDULE OF CONTINUING EDUCATION COURSES FOR RN s and CNAs. January 2018 WALK INS ARE ACCEPTED BUT WE ADVISE STUDENTS TO PRE-REGISTER BEFORE THURSDAY SCHEDULE OF CONTINUING EDUCATION COURSES FOR RN s and CNAs January 201 DATE DAY TIME TOPICS January 04 January 11 January 1 January 25 9:00AM 9:00AM 9:00AM 9:00AM 1. Understanding Fibromyalagia 2. Diabetes

More information

ATYPICAL ANTIPSYCHOTICS

ATYPICAL ANTIPSYCHOTICS Step Therapy CareOregon 2018 Last Updated: 07/27/2018 ATYPICAL ANTIPSYCHOTICS Fanapt Fanapt Titration Pack Paliperidone Er Vraylar The following criteria applies to members who newly start on the drug:

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride) PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride) Please read this information carefully before you start to take your medicine.

More information

Bupivacaine Hydrochloride Anesthetic US DMF Available for Reference / CEP

Bupivacaine Hydrochloride Anesthetic US DMF Available for Reference / CEP Generic APIs Commercial APIs Product Name Therapeutic Category Status Bisacodyl Laxative US DMF / CEP Bosentan monohydrate (1) Antihypertensive ASMF Bupivacaine Hydrochloride Anesthetic US DMF Available

More information

SCHEDULE OF CONTINUING EDUCATION COURSES FOR RN s and CNAs. January 2019

SCHEDULE OF CONTINUING EDUCATION COURSES FOR RN s and CNAs. January 2019 January 2019 DATE DAY TIME TOPICS TOTAL January 03 1. Alcoholism 2. Nutrition for the Elderly 3. Uterine Fibroids 4. HIPAA 5.Arthritis 6. Childhood Obesity January 10 1. Understanding Epilepsy: Latest

More information

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication. ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE

More information

Marketing authorisations granted in September 2012

Marketing authorisations granted in September 2012 PL 00037/0648 03/09/2012 ABBOTT LABORATORIES LIMITED LEVELANZ 250 MG FILM-COATED TABLETS LEVETIRACETAM 250 MILLIGRAMMES POM PL 00037/0649 03/09/2012 ABBOTT LABORATORIES LIMITED LEVELANZ 500 MG FILM-COATED

More information

2018 Step Therapy Criteria

2018 Step Therapy Criteria 2018 Step Therapy Criteria ANGIOTENSIN RECEPTOR BLOCKERS... 2 ANTIDEPRESSANTS... 3 ANTIDEPRESSANTS, MISCELLANEOUS... 4 ANTIDEPRESSANTS, OTHER... 5 ANTIDIABETIC AGENTS... 6 ANTIGOUT AGENTS... 7 ANTIHYPERTENSIVE

More information

Pharmacology for the Health Care Professions

Pharmacology for the Health Care Professions Pharmacology for the Health Care Professions Christine M. Thorp University of Salford, UK )WILEY-BLACKWELL A John Wiley & Sons, Ltd., Publication Contents Foreword Preface Acknowledgements xüi xv xvii

More information

HEALTH MATTERS, INC. SUMMARY OF PROJECTS AND KEY ACCOMPLISHMENTS TO 2016

HEALTH MATTERS, INC. SUMMARY OF PROJECTS AND KEY ACCOMPLISHMENTS TO 2016 Selected 2016 Highlights Epidemiologic research on chronic kidney disease and fistula patency, solid and hematologic malignancies Health economics and outcomes research on beta3-agonist treatment for overactive

More information

CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM 10% [100 mg/ml]

CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM 10% [100 mg/ml] CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM 10% [100 mg/ml] Human Normal Immunoglobulin Solution for Intravenous Infusion. OCTAGAM 10% [100 mg/ml] is available in single use bottles of 20 ml, 50 ml, 100

More information

R&D Pipeline (May 2010)

R&D Pipeline (May 2010) R&D Pipeline (May 2010) 1 Global development (1) Filed Stage in the Most Advanced Territory YM617 tamsulosin Alpha-1 receptor antagonist Lower urinary tract syndrome in male patients (June 2007) New indication

More information

VI.2.2 Summary of treatment benefits

VI.2.2 Summary of treatment benefits EU-Risk Management Plan for Bimatoprost V01 aetiology), both OAG and ACG can be secondary conditions. Secondary glaucoma refers to any case in which another disorder (e.g. injury, inflammation, vascular

More information

Drugs approved from 1st January 2015 till present. S.NO Name Of Drug Indication Date of Approval 1 Levocetirizine ODS 2.5mg /5mg (Additional

Drugs approved from 1st January 2015 till present. S.NO Name Of Drug Indication Date of Approval 1 Levocetirizine ODS 2.5mg /5mg (Additional Drugs approved from 1st January 2015 till present S.NO Name Of Drug Indication Date of 1 Levocetirizine ODS 2.5mg /5mg dosage form) For allergic rhinitis and chronic urticaria. 14.01.15 2 Decitabine Injection

More information

Step Therapy Approval Criteria

Step Therapy Approval Criteria Effective Date: 10/01/2016 This document contains Step Therapy Approval Criteria for the following medications: 1. Colcrys (colchicine) 2. Cymbalta (duloxetine) 3. Dovonex (calcipotriene) 4. Enbrel (etanercept)

More information

Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology

Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Document type and title: Joint formulary - Ophthalmology Authorised document folder: New or replacing

More information

2017 Step Therapy Criteria

2017 Step Therapy Criteria FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.

More information

QiG INS Conference May 22, 2011

QiG INS Conference May 22, 2011 Strategy & Vision Growth Electrochem Medical Device Evolution QiG Cardio vascular QiG INS Conference May 22, 2011 Greatbatch Medical Neuro modulation 1 GREATBATCH TODAY 2010 Revenue by Product Line NYSE:

More information

Updates to the Alberta Drug Benefit List. Effective July 1, 2018

Updates to the Alberta Drug Benefit List. Effective July 1, 2018 Updates to the Alberta Drug Benefit List Effective July 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

AVAILABLE DOSSIERS. Product name Pharmaceutical form Strength Reference Therapeutic class

AVAILABLE DOSSIERS. Product name Pharmaceutical form Strength Reference Therapeutic class DOSSIER LIST AVAILABLE DOSSIERS Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM Esomeprazole sodium Omeprazole sodium injection / 40 mg Nexium / AstraZeneca

More information

Drug Guide. April New Specialty Drug Approvals. New Formulations for Existing Drugs

Drug Guide. April New Specialty Drug Approvals. New Formulations for Existing Drugs April 2013 The MedTrak Drug Guide provides a monthly update on recent approvals by the Food and Drug Administration (FDA). Use the chart below as a valuable reference tool. Additional detailed information

More information

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution

More information

Initial Consultation

Initial Consultation Today s Date: Initial Consultation Thank you for choosing Apollo Health and Wellness. Please take your time to fill out this form. It will help us to concentrate on areas of your health that need attention

More information

Medicines Procurement South West

Medicines Procurement South West MHRA Marketing Authorisations January 2010 to October 2016 Medicines Procurement South West Note: This document is intended to support Trusts with local horizon scanning and supply chain management. The

More information

BNF CHAPTER 11: EYE 1 January 2018

BNF CHAPTER 11: EYE 1 January 2018 BNF CHAPTER 11: EYE 1 BNF 11.3.1 ANTIBACTERIALS First Choice. Broad spectrum. Chloramphenicol 0.5% Eye Drops Administration Alternative Administration Eye drops, apply 1 drop at least every 2 hours then

More information

PORTFOLIO MADE WITH CARE. FDF Generics Chlorhexidine API

PORTFOLIO MADE WITH CARE. FDF Generics Chlorhexidine API PORTFOLIO MADE WITH CARE FDF Generics Chlorhexidine API MADE WITH CARE Generics API LONG-TERM WORLDWIDE EXPERIENCE FDF HPAPI Intermediates API SEAMLESS DEVELOPMENT FDF FIRST TO MARKET GENERICS FDF MOLECULE

More information

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) 2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) In some cases, UCare requires you to first try certain drugs to

More information

PSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX

PSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX A acamprosate ADHD Generic Methylphenidate Equivalence, 84 Methylphenidate in Pregnancy, 9 Stimulants in Pregnancy, 50 adverse effects Antidepressant-Induced Jitteriness, 94 Antidepressants and Sexual

More information

ANNOUNCEMENT. Dear Valued Customer:

ANNOUNCEMENT. Dear Valued Customer: ANNOUNCEMENT Dear Valued Customer: This is to notify you that Ranbaxy Canada s products will not be currently distributed to you through Kohl and Frisch; however Kohl and Frisch will continue their support

More information

PROFMED MEDICAL SCHEME CHRONIC MEDICINE BENEFIT GENERAL INFORMATION

PROFMED MEDICAL SCHEME CHRONIC MEDICINE BENEFIT GENERAL INFORMATION PROFMED MEDICAL SCHEME CHRONIC MEDICINE BENEFIT GENERAL INFORMATION The Prescribed Minimum Benefit Chronic Disease List In terms of the Medical Schemes Act Regulations that came into effect on 1 January

More information

ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet

ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet ALPHA BLOCKERS RAPAFLO 4 MG CAPSULE RAPAFLO 8 MG CAPSULE drug may be given. alfuzosin extended release tablet doxazosin tablet tamsulosin capsule terazosin capsule 1 ANTIDEPRESSANTS - SNRI FETZIMA 10 MG

More information

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

NEXIUM INTRAVENOUS esomeprazole sodium

NEXIUM INTRAVENOUS esomeprazole sodium NEXIUM INTRAVENOUS esomeprazole sodium Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about NEXIUM Intravenous (IV). It does not contain

More information

North of Tyne Area Prescribing Committee DECISION SUMMARY North of Tyne Area Prescribing Committee Summary of decisions made regarding new product requests considered at a meeting of the Committee on Tuesday

More information

ALLERGIC CONJUNCTIVITIS AGENTS

ALLERGIC CONJUNCTIVITIS AGENTS 2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops

More information

current patent) ----Key intermediates for Sartan series,tatin series,liptin iiiprostaglandin Derivatives---Cloprostenol Key intermediates etc.

current patent) ----Key intermediates for Sartan series,tatin series,liptin iiiprostaglandin Derivatives---Cloprostenol Key intermediates etc. Our Main Service Custom Developing / Custom Manufacturing for APIs/ key intermediates and Finish Dosage form. Import & Export / Technology Transfer for Finish Dosage Form. ⅡOur Hot Items i"me-too" new

More information

South London and the Maudsley NHS Foundation Trust Medicines Formulary

South London and the Maudsley NHS Foundation Trust Medicines Formulary South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1

More information

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015 Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A 294.3 for use in Northern Ireland) Sep 2015 BNF 1.3.5 Proton pump inhibitors Lansoprazole orodispersible

More information

Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron

Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains

More information

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

2015 Step Therapy Prior Authorization Medical Necessity Guidelines Tufts Health Unify 2015 Step Therapy Prior Authorization Medical Necessity Guidelines Effective: 01/01/2015 Updated: 10/01/2015 Tufts Health Plan P.O. Box 9194 Watertown, MA 02471-9194 Phone: 855-393-3154

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension

More information

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets

More information

NI Formulary: Chapter 4 Central Nervous system

NI Formulary: Chapter 4 Central Nervous system Hypnotics Anxiolytics Acute state Non drug treatment Temazepam tablets 10mg, 20mg; oral solution 10mg/5ml or Zolpidem tablets 5mg, 10mg or Zopiclone 3.75mg, 7.5mg Non drug treatment Diazepam tablets 2mg,

More information

Public Dissemination Effective: January 2018

Public Dissemination Effective: January 2018 Board of Pharmacy Specialties Board Certified Geriatric Pharmacist (BCGP) Detailed Content Outline 1. GENERAL PRINCIPLES OF AGING (20%) A. Apply the knowledge of physiologic changes associated with aging

More information

List of Chronic Conditions under the Community Health Assist Scheme (CHAS)

List of Chronic Conditions under the Community Health Assist Scheme (CHAS) List of Chronic s under the Community Health Assist Scheme (CHAS) Chronic Diabetes Mellitus Hypertension Lipid Disorders Stroke Asthma Chronic Obstructive Pulmonary Disease (COPD) Schizophrenia Major Depression

More information

R&D Pipeline (November 2005)

R&D Pipeline (November 2005) R&D Pipeline (November 2005) 1Japan (1)Filed Code No YM905 YM177 YM152 FK463 Generic Name (Filing Date ) solifenacin (Aug 2004) celecoxib (Dec 2002) finasteride (Dec1994) micafungin (July 2004) (Oct 2005)

More information

City State Zip. Cell Phone. Other Phone. Gender Male Female Status Single Married Divorced Widowed. Height Weight EXERCISE Yes No Times per Week

City State Zip. Cell Phone. Other Phone. Gender Male Female Status Single Married Divorced Widowed. Height Weight EXERCISE Yes No Times per Week Patient Name (First Middle Last) Date of Birth Social Security # Address City State Zip Home Phone Work Phone Cell Phone Other Phone Email Place of Birth Occupation Retired Yes No Gender Male Female Status

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.

More information

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

Table 1: Price increases for Brand Name Drugs with Generic Equivalents Table 1: Price increases for Brand Name Drugs with Generic Equivalents Brand Name Medication and Dose Total % Change Since 10/2012 ACTOS 15 MG TABLET 6.36 11.03 73.39% ACTOS 30 MG TABLET 9.7 16.80 73.23%

More information

CHRONIC MEDICATION PROGRAMME INCLUDES PRESCRIBED MINIMUM BENEFIT CHRONIC DISEASE LIST (CDL)

CHRONIC MEDICATION PROGRAMME INCLUDES PRESCRIBED MINIMUM BENEFIT CHRONIC DISEASE LIST (CDL) CHRONIC MEDICATION PROGRAMME INCLUDES PRESCRIBED MINIMUM BENEFIT CHRONIC DISEASE LIST (CDL) A. GENERAL INFORMATION LIST OF CHRONIC CONDITIONS Conditions covered under KeyHealth s chronic medication benefit

More information

LECOM Health Ophthalmology

LECOM Health Ophthalmology Patient Name: Date of Birth: New Patient Questionnaire Your answers will be used by your healthcare provider get an accurate history of your medical conditions and ocular concerns. If you are uncomfortable

More information

What Is. Is the combination of two or more things to produce something that neither component could produce alone.

What Is. Is the combination of two or more things to produce something that neither component could produce alone. What Is Is the combination of two or more things to produce something that neither component could produce alone. 1 Our Skills Synergy Swiss Pharma has an experienced team with collective knowledge and

More information

HYDROGEN PEROXIDE ADMINISTRATION LEVELS

HYDROGEN PEROXIDE ADMINISTRATION LEVELS HYDROGEN PEROXIDE ADMINISTRATION LEVELS CMG Archives http://www.campbellmgold.com (2012) IMPORTANT The health information contained herein is not meant as a substitute for advice from your physician, or

More information

TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018

TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018 1 Tennessee CoverRx List Run : 04/26/18 Dosage Form amiodarone HCl 200 MG TABLET ORAL 04/25/2018 0.16102 0.14405 11.8 hydralazine HCl 100 MG TABLET ORAL 04/25/2015 0.11390 0.10854 4.9 hydralazine HCl 25

More information

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription

More information

Advanced Control Formulary Change Summary Report Effective

Advanced Control Formulary Change Summary Report Effective This report highlights all changes (additions, deletions, and removals) to the CVS Caremark Advanced Control Formulary. ADDITIONS: Brand Agents: Mepron (atovaquone) suspension Mydayis (amphetaminedextroamphetamine)

More information

PRESCRIBING GUIDELINES

PRESCRIBING GUIDELINES The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS. 1 ANTICONVULSANTS

More information

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) 2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) In some cases, UCare requires you to first try certain drugs to

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 28 May 2008 COSOPT 20 mg/5 mg/ml, eye drops, solution in single dose container Box of 60 0.2 ml single dose containers

More information